Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing
Volume 41, Issue 9 (Sep 2003)

Issues

Plasma Adiponectin and Hyperglycaemia in Diabetic Patients

Edoardo Mannucci / Agostino Ognibene / Francesco Cremasco / Ilaria Dicembrini / Gianluca Bardini / Marco Brogi / Alessandro Terreni / Anna Caldini / Gianni Messeri / Carlo M. Rotella
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2003.175

Abstract

The insulin-sensitising adipose hormone adiponectin is reduced in type 2 diabetic patients. We assessed the relationships between plasma adiponectin and chronic hyperglycaemia. Adiponectin levels and glycated haemoglobin (HbA1c) were measured at enrolment and after 90 days in 16 patients with type 2 diabetes aged (mean ± SEM) 63.0±0.6 years, with body mass index (BMI) 30.2±0.5 kg/m2 and HbA1c concentration 7.4± 0.1%, who did not modify their hypoglycaemic treatment during the observation period. Furthermore, plasma adiponectin was measured in 29 adult patients with type 1 diabetes and compared with 29 control subjects matched for sex, age, BMI, waist circumference and bioimpedance-estimated fat mass. In type 2 diabetic patients at enrolment, adiponectin concentration correlated with BMI (r = −0.46; p < 0.05), but not with HbA1c. During the prospective observation, variations of adiponectin showed a significant correlation with variations of BMI (r = −0.47; p < 0.01), but not with variations of HbA1c concentration. These results were confirmed by multivariate analysis after adjustment for sex and age. Adiponectin levels in type 1 diabetic patients (380.8±13.7 ng/ml in women, 192.5±13.9 ng/ml in men) were significantly (p < 0.05) higher than in control subjects (277.6±11.0 ng/ml in women, 102.7±5.1 ng/ml in men); plasma adiponectin correlated significantly with BMI and waist circumference, but not with HbA1c. In conclusion, the reduction of plasma adiponectin levels in type 2 diabetic patients does not appear to be determined by chronic hyperglycaemia. Adiponectin levels are increased in type 1 diabetes, but this phenomenon is not attributable to differences in nutritional status or body composition.l21

About the article

Published Online: 2005-06-01

Published in Print: 2003-09-16


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2003.175. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
L. Qi, E. Rimm, S. Liu, N. Rifai, and F. B. Hu
Diabetes Care, 2005, Volume 28, Number 5, Page 1022
[2]
Romel Somwar, Xiangping Fang, and Gary Sweeney
Drug Discovery Today: Disease Models, 2005, Volume 2, Number 3, Page 183
[3]
J. E. Morley
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2004, Volume 59, Number 2, Page M139
[4]
Machi Furuta, Masanori Tamai, Tadashi Hanabusa, Yasuhisa Yamamoto, Kishio Nanjo, and Tokio Sanke
Diabetes Research and Clinical Practice, 2006, Volume 72, Number 3, Page 302
[5]
J A Wagner, E C Wright, M M Ennis, M Prince, J Kochan, D J R Nunez, B Schneider, M-D Wang, Y Chen, S Ghosh, B J Musser, and M T Vassileva
Clinical Pharmacology & Therapeutics, 2009, Volume 86, Number 6, Page 619
[6]
M. M. Barnes, D. Curran-Everett, R. F. Hamman, D. Maahs, E. J. Mayer-Davis, R. B. D’Agostino, N. West, and D. Dabelea
Diabetic Medicine, 2008, Volume 25, Number 3, Page 365
[7]
Harpal S. Randeva, Manu Vatish, Bee K. Tan, Zubair Qureshi, Padmabushan Boovalingam, Krzysztof C. Lewandowski, and Paul O'Hare
Clinical Endocrinology, 2006, Volume 65, Number 1, Page 17
[8]
J. Frystyk, L. Tarnow, T. Krarup Hansen, H.-H. Parving, and A. Flyvbjerg
Diabetologia, 2005, Volume 48, Number 9, Page 1911

Comments (0)

Please log in or register to comment.
Log in